Monopar Therapeutics Inc.

NASDAQ: MNPR · Real-Time Price · USD
35.87
0.01 (0.03%)
At close: Aug 15, 2025, 3:59 PM
35.71
-0.45%
After-hours: Aug 15, 2025, 04:10 PM EDT

Monopar Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-5.09B -15.27M -14.28M -5.17M -7.12M -7.61M -8.4M -9.48M -9.93M -10.49M -10.52M -10.3M -10.36M -9.68M -9.1M -8.55M -7.73M -7.1M
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
2.14B 863.81M 862.79M 862.98M 1.61M 1.75M 1.9M 1.82M 1.73M 1.62M 1.64M 1.6M 1.6M 1.6M 1.47M 1.45M 1.34M 1.35M
Other Working Capital
2.96M -608.33K 2.98M 28.02K 61.73K 8.81K -20.41K -21.97K -54.15K -48.52K 34.05K -13.29K -29.01K -12.59K -86.2K -2.25K 85.59K -13.58K
Other Non-Cash Items
-3.8B -859M -859M -863.55M n/a 845.02K 1.57M 770.71K 770.43K -809.58K -505.58K 306.42K 562.47K 1.36M 1.06M 932.13K 676.35K 616.37K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
4.74M 45.82K 4.1M -206.19K -1.31M -1.38M -1.35M 53.36K 374K 1.84M 1.65M 743.23K 1.01M 229.45K 317.77K 698.08K 628.2K 394.73K
Operating Cash Flow
-6.74B -10.41M -6.4M -5.95M -6.82M -7.24M -7.86M -7.61M -7.82M -7.03M -7.23M -7.96M -7.75M -7.85M -7.32M -6.53M -5.89M -5.47M
Capital Expenditures
n/a -4 3.00 3.00 6.00 6.00 3.00 3.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-3.15B -16.27M -15.32M -976.49K -3.95M -5.91M -7.88M -12.81M -9.84M -7.88M -4.92M n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
4B 2.59M 985.73K 3.95M 5.92M 10.83M 12.81M 9.85M 6.89M 1.98M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a 2.95K 1.97K -2.95K -2.95K -5.9K -4.92K n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
848.11M -13.68M -14.34M 2.97M 1.97M 4.93M 4.93M -2.96M -2.95M -5.9M -4.92M n/a n/a n/a n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-16.53 -16.53 -16.53 -16.53 n/a n/a n/a n/a -10.67K -10.7K -10.72K -10.73K -64.07 -58.42 -41.75 -33.98 -24 n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-432.63M -224.59K -104.2K -42.58K -34.27K -40.88K -46.97K -12.25K -17.11K -65.95K -65.79K -102.96K -99.88K -58.42K -45.77K -45.14K -54.08K 2.81K
Financial Cash Flow
-376.41M 55.99M 59.29M 3.49M 3.75M 4.4M 2.03M 1.83M 1.56M 854.34K 32.87K -113.64K -99.88K -58.42K 10.88M 10.88M 17.62M 18.6M
Net Cash Flow
39.5B 31.9M 38.55M 504.73K -1.09M 2.08M -920.11K -8.8M -9.25M -12.09M -12.12M -8.03M -7.83M -7.9M 3.57M 4.36M 11.75M 13.13M
Free Cash Flow
-6.74B -10.41M -6.4M -5.95M -6.82M -7.24M -7.86M -7.61M -7.82M -7.03M -7.23M -7.96M -7.75M -7.85M -7.32M -6.53M -5.89M -5.47M